Stanford Shoor

3.5k total citations · 2 hit papers
23 papers, 2.8k citations indexed

About

Stanford Shoor is a scholar working on Rheumatology, Hematology and Surgery. According to data from OpenAlex, Stanford Shoor has authored 23 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Rheumatology, 5 papers in Hematology and 4 papers in Surgery. Recurrent topics in Stanford Shoor's work include Rheumatoid Arthritis Research and Therapies (5 papers), Autoimmune and Inflammatory Disorders Research (4 papers) and Antiplatelet Therapy and Cardiovascular Diseases (3 papers). Stanford Shoor is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (5 papers), Autoimmune and Inflammatory Disorders Research (4 papers) and Antiplatelet Therapy and Cardiovascular Diseases (3 papers). Stanford Shoor collaborates with scholars based in United States. Stanford Shoor's co-authors include Kate Lorig, Halsted R. Holman, Robert L. Chastain, Ann O’Leary, Michele M. Spence, David Campen, Rita L. Hui, David J. Graham, Gerald Levy and Craig Cheetham and has published in prestigious journals such as The Lancet, Nature Immunology and Medical Care.

In The Last Decade

Stanford Shoor

20 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Development and evaluation of a scale to measure perceived self‐efficacy in people with arthritis

1989 1.3k citations Kate Lorig, Robert L. Chastain et al. Arthritis & Rheumatism profile →
Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study

2005 683 citations David J. Graham, David Campen et al. The Lancet profile →

Peers

Countries citing papers authored by Stanford Shoor

Since Specialization

Citations

This map shows the geographic impact of Stanford Shoor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stanford Shoor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stanford Shoor more than expected).

Fields of papers citing papers by Stanford Shoor

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stanford Shoor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stanford Shoor. The network helps show where Stanford Shoor may publish in the future.

Co-authorship network of co-authors of Stanford Shoor

This figure shows the co-authorship network connecting the top 25 collaborators of Stanford Shoor. A scholar is included among the top collaborators of Stanford Shoor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stanford Shoor. Stanford Shoor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Sarcoidosis: Review of Diagnosis and Treatment 2021 ·Stanford Shoor	0
2	Reactivation of Chagas Disease in a Patient With an Autoimmune Rheumatic Disease: Case Report and Review of the Literature 2021 ·Open Forum Infectious Diseases ·(unknown), Ashwin Nayak, (unknown), José Francisco Suárez, J Ferguson, Karen B. Jacobson, Susan P. Montgomery, Michael S. Chang, Gordon H. Bae, Shyam S. Raghavan, Hannah Wang, (unknown), Indre Budvytiene, Stanford Shoor, Niaz Banaei, Kerri E. Rieger, Stan Deresinski, Marisa Holubar, Brian G. Blackburn	9
3	Risk of Serious Infection Associated with Agents that Target T-Cell Activation and Interleukin-17 and Interleukin-23 Cytokines 2020 ·Infectious Disease Clinics of North America ·Stanford Shoor	7
4	TNF-alpha inhibition for the treatment of cardiac sarcoidosis 2019 ·Seminars in Arthritis and Rheumatism ·Matthew Baker, Khushboo Sheth, Ronald Witteles, Mark C. Genovese, Stanford Shoor, Julia F. Simard	30
5	N-myristoyltransferase deficiency impairs activation of kinase AMPK and promotes synovial tissue inflammation 2019 ·Nature Immunology ·Zhenke Wen, Ke Jin, Yi Shen, Zhen Yang, Yinyin Li, Bowen Wu, Lü Tian, Stanford Shoor, (unknown), Jörg J. Goronzy, Cornelia M. Weyand	123
6	Abatacept in Steroid-Dependent Minimal Change Disease and CD80-uria 2019 ·Kidney International Reports ·(unknown), Stanford Shoor, John Higgins, Gabriel Cara‐Fuentes, Richard J. Johnson	10
7	Development and validation of a rheumatologist satisfaction with practice scale 2019 ·Medicine ·Khushboo Sheth, Antonia Valenzuela, Stanford Shoor, Philip L. Ritter, Kate Lorig	0
8	Incidence and Prevalence of Juvenile Idiopathic Arthritis Among Children in a Managed Care Population, 1996–2009 2013 ·The Journal of Rheumatology ·Leslie R. Harrold, (unknown), Stanford Shoor, Jeffrey R. Curtis, Maryam M. Asgari, Joel M. Gelfand, Jashin J. Wu, Lisa J. Herrinton	57
9	Short-term and long-term success of electrical cardioversion in atrial fibrillation in managed care system 2009 ·International Archives of Medicine ·Suman S. Kuppahally, Elyse Foster, Stanford Shoor, Anthony Steimle	25
10	Review: Anti–tumor necrosis factor antibody therapy for rheumatoid arthritis increases risk for serious infection and malignancy 2006 ·ACP Journal Club ·Stanford Shoor	6
11	Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study breakdown → 2005 ·The Lancet ·David J. Graham, David Campen, Rita L. Hui, Michele M. Spence, Craig Cheetham, Gerald Levy, Stanford Shoor, Wayne A. Ray	683
12	Review: intra-articular corticosteroid injections are better than placebo for improving symptoms of knee osteoarthritis 2005 ·Evidence-Based Medicine ·Stanford Shoor	1
13	Etanercept plus methotrexate reduced symptoms and disease activity in adult-onset rheumatoid arthritis 2004 ·ACP Journal Club ·Stanford Shoor	1
14	A cohort study of systemic and local complications of toe prostheses. 2003 ·PubMed ·Gail Husson, (unknown), W. Timothy Brox, William D. Finkle, Allan Bernstein, Stanford Shoor, Sander Greenland	3
15	Self-Care and the Doctor-Patient Relationship 2002 ·Medical Care ·Stanford Shoor, Kate Lorig	33
16	Athletes, Nonsteroidal Anti-inflammatory Drugs, Coxibs, and the Gastrointestinal Tract 2002 ·Current Sports Medicine Reports ·Stanford Shoor	11
17	A Festschrift in Honor of Halsted R. Holman, MD 2002 ·Medical Care ·Matthew H. Liang, Harold I. Goldberg, Stanford Shoor, Kate Lorig	1
18	Development and evaluation of a scale to measure perceived self‐efficacy in people with arthritis breakdown → 1989 ·Arthritis & Rheumatism ·Kate Lorig, Robert L. Chastain, (unknown), Stanford Shoor, Halsted R. Holman	1332
19	A cognitive-behavioral treatment for rheumatoid arthritis. 1988 ·Health Psychology ·Ann O’Leary, Stanford Shoor, Kate Lorig, Halsted R. Holman	217
20	A cognitive-behavioral treatment for rheumatoid arthritis. 1988 ·Health Psychology ·Ann O’Leary, Stanford Shoor, Kate Lorig, Halsted R. Holman	197

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact